The CRONOS-ADM Registry

The CRONOS-ADM (Coronary CT angiography evaluation for clinical outcomes in asymptomatic patients with type 2 diabetes mellitus) registry is a large, prospective observational registry of demographic, clinical and laboratory data with long-term clinical outcome of asymptomatic diabetic patients without history of CAD or angina or angina-equivalent symptoms at two affiliated hospitals of The Catholic University of Korea.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Asymptomatic Patients With Type 2 Diabetes Mellitus Arterial Occlusive Diseases Arteriosclerosis Atherosclerosis Cardiovascular Disease Cardiovascular Diseases Coronary Artery Disease Coronary Disease Heart Diseases Myocardial Ischemia Vascular Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Seoul St. Mary's Hospital

Seoul, 137-701, South Korea

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Age > 18 years
Asymptomatic type 2 diabetes mellitus
Prospective data collection for CAD risk factors

Treatment and study plan

Primary outcomes

Time to major adverse events

Time frame: up to median 3 years follow up

Sponsors and collaborators

Lead sponsor

Seoul St. Mary's Hospital

Other

Registry information

Official study title

Coronary CT Angiography Evaluation for Clinical Outcomes in Asymptomatic Patients With Type 2 Diabetes Mellitus

Important dates

Study start: 2006
Primary completion: 2010
First posted: Feb 25, 2014
Registry last updated: Feb 25, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed